You are in:Home/Publications/Plasma Fibrinogen Levels As A Prognostic Biomarker In Acute Ischemic Stroke.

Dr. Shaimaa Mohammed Kasem :: Publications:

Title:
Plasma Fibrinogen Levels As A Prognostic Biomarker In Acute Ischemic Stroke.
Authors: Dr. Ramiz Mahmoud Elmowafy1,Dr. Abo Zaid Abd-Allah Khodair2,Dr. Abd Elnaser Ali Morad3,Dr. Shaimaa Mohamed Kassem4 .
Year: 2017
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: Local
Paper Link: Not Available
Full paper Shaimaa Mohammed Kasem_O1601026265.pdf
Supplementary materials Not Available
Abstract:

Background: Stroke patients have significantly higher fibrinogen levels. Previous studies revealed that, hyperfibrinogenemia at the beginning of acute ischemic stroke is associated with increased risk of death within one year after stroke. Little is known about the influence of fibrinogen levels on functional outcome. Aim: Investigate the prognostic influence of the change in the plasma fibrinogen levels after acute ischemic stroke on the functional outcome of the patients. Methods: Fibrinogen levels were determined within 24 hours and at day 5 of stroke onset. Modified Rankin Scale (mRS) at 90 days quantified functional outcomes. Pearson’s product correlation coefficient “r” was used to assess linear correlation between fibrinogen levels and mRS. Results Plasma fibrinogen levels are high in patients with acute ischemic stroke. The mean plasma fibrinogen level at the first 24 hours was 3.66 ± 0.796 g/L, while after 5 days was higher with a mean of 4.72 ± 1.669 g/L, with significant correlation with functional outcome at 90 days p

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus